一位多发性硬化症患者在接受奥瑞珠单抗第二个周期治疗后出现迟发性中性粒细胞减少症复发：病例报告 - Suppr

Suppr

超能文献

Late-onset neutropenia (LON) recur in a MS patient after the second cycle of ocrelizumab: a case report.

作者信息

Maniscalco Giorgia T, Allegorico Lia, Di Battista Maria Elena, Annunziata Mario, Salvatore Simona, Manzo Valentino

机构信息

Multiple Sclerosis Center, "A. Cardarelli" Hospital, Naples, Italy.

Neurological Clinic and Stroke Unit, "A. Cardarelli" Hospital, Naples, Italy.

出版信息

Neurol Sci. 2021 Sep;42(9):3933-3935. doi: 10.1007/s10072-021-05379-9. Epub 2021 Jun 25.

DOI:10.1007/s10072-021-05379-9

PMID:34170432

Abstract

摘要

相似文献

Late-onset neutropenia (LON) recur in a MS patient after the second cycle of ocrelizumab: a case report.

Neurol Sci. 2021 Sep;42(9):3933-3935. doi: 10.1007/s10072-021-05379-9. Epub 2021 Jun 25.

Late-onset neutropenia in a multiple sclerosis patient after first dose ocrelizumab switched from rituximab.

Mult Scler Relat Disord. 2020 Aug;43:102155. doi: 10.1016/j.msard.2020.102155. Epub 2020 May 13.

Recurrence of severe symptomatic late-onset neutropenia on ocrelizumab.

Mult Scler. 2024 Jan;30(1):131-133. doi: 10.1177/13524585231206218. Epub 2023 Oct 27.

Late onset absolute neutropenia associated with ocrelizumab treatment in multiple sclerosis: A case report and review of the literature.

J Neurol Sci. 2020 Feb 15;409:116603. doi: 10.1016/j.jns.2019.116603. Epub 2019 Nov 28.

Rituximab- and ocrelizumab-induced early- and late-onset neutropenia in a multiple sclerosis patient.

Neurol Sci. 2021 Sep;42(9):3893-3895. doi: 10.1007/s10072-021-05357-1. Epub 2021 Jun 1.

Neutropenia after rituximab treatment: new insights on a late complication.

Curr Opin Hematol. 2012 Jan;19(1):32-8. doi: 10.1097/MOH.0b013e32834da987.

Managing patients with late-onset neutropenia during treatment with ocrelizumab.

Mult Scler. 2024 Jan;30(1):134. doi: 10.1177/13524585231206219. Epub 2023 Oct 27.

Late-onset neutropenia after rituximab treatment: case series and comprehensive review of the literature.

Medicine (Baltimore). 2010 Sep;89(5):308-318. doi: 10.1097/MD.0b013e3181f2caef.

Late-onset neutropenia following ocrelizumab therapy for multiple sclerosis.

Neurology. 2019 Feb 26;92(9):435-436. doi: 10.1212/WNL.0000000000006924. Epub 2019 Jan 11.

Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced B-cell recovery.

Haematologica. 2007 Feb;92(2):e20-3. doi: 10.3324/haematol.11031.

引用本文的文献

Can an active lifestyle maintain cognitive efficiency in older adults? A pilot study of the relationship between physical activity and graphic fluency.

BMC Psychol. 2025 Mar 28;13(1):312. doi: 10.1186/s40359-025-02466-w.

Disease-modifying therapies and hematological disorders: a systematic review of case reports and case series.

Front Neurol. 2024 Jun 18;15:1386527. doi: 10.3389/fneur.2024.1386527. eCollection 2024.

Remote smartphone gait monitoring and fall prediction in Parkinson's disease during the COVID-19 lockdown.

Neurol Sci. 2021 Aug;42(8):3089-3092. doi: 10.1007/s10072-021-05351-7. Epub 2021 May 27.

本文引用的文献

Validation of inter-eye difference thresholds in optical coherence tomography for identification of optic neuritis in multiple sclerosis.

Mult Scler Relat Disord. 2020 Oct;45:102403. doi: 10.1016/j.msard.2020.102403. Epub 2020 Jul 17.

Palatal myoclonus, abnormal eye movements, and olivary hypertrophy in GAD65-related disorder.

Neurology. 2020 Feb 11;94(6):273-275. doi: 10.1212/WNL.0000000000008926. Epub 2019 Dec 31.

Late onset absolute neutropenia associated with ocrelizumab treatment in multiple sclerosis: A case report and review of the literature.

J Neurol Sci. 2020 Feb 15;409:116603. doi: 10.1016/j.jns.2019.116603. Epub 2019 Nov 28.

Rituximab associated late-onset neutropenia-a rheumatology case series and review of the literature.

Clin Rheumatol. 2016 Oct;35(10):2457-62. doi: 10.1007/s10067-016-3313-y. Epub 2016 May 21.

Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced B-cell recovery.

Haematologica. 2007 Feb;92(2):e20-3. doi: 10.3324/haematol.11031.

Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow.

J Exp Med. 2005 Jun 6;201(11):1771-80. doi: 10.1084/jem.20041419.

B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis.

Blood. 2005 Aug 1;106(3):795-802. doi: 10.1182/blood-2004-08-3198. Epub 2005 Feb 17.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验